In a filing, Zai Lab Limited ADR revealed its Officer Du Ying acquired Company’s shares for reported $1.65 million on Mar 05 ’25. In the deal valued at $35.55 per share,46,389 shares were bought.
Then, GAYNOR RICHARD bought 2,500 shares, generating $87,675 in total proceeds.
Before that, Edmondson Frazor Titus III sold 14,544 shares. Zai Lab Limited ADR shares valued at $479,661 were divested by the Chief Legal Officer at a price of $32.98 per share. As a result of the transaction, Edmondson Frazor Titus III now holds 14,328 shares, worth roughly $0.5 million.
Scotiabank initiated its Zai Lab Limited ADR [ZLAB] rating to a Sector outperform in a research note published on March 07, 2025; the price target was $55. A number of analysts have revised their coverage, including BofA Securities’s analysts, who decreased its forecast for the stock in early March from “a Buy” to “a Neutral”. Morgan Stanley began covering ZLAB with “an Overweight” recommendation on December 14, 2023. Cantor Fitzgerald started covering the stock on August 10, 2023. It rated ZLAB as “an Overweight”.
Price Performance Review of ZLAB
On Monday, Zai Lab Limited ADR [NASDAQ:ZLAB] saw its stock fall -4.75% to $34.69. Over the last five days, the stock has gained 9.33%. Zai Lab Limited ADR shares have risen nearly 32.46% since the year began. Nevertheless, the stocks have risen 75.20% over the past one year. While a 52-week high of $37.99 was reached on 03/07/25, a 52-week low of $13.48 was recorded on 01/15/25. SMA at 50 days reached $28.65, while 200 days put it at $23.97.
Levels Of Support And Resistance For ZLAB Stock
The 24-hour chart illustrates a support level at 33.97, which if violated will result in even more drops to 33.25. On the upside, there is a resistance level at 35.76. A further resistance level may holdings at 36.84. The Relative Strength Index (RSI) on the 14-day chart is 60.41, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at 1.58, which suggests price will go up in the next trading period. Percent R suggests that price movement has been low at 44.72%. Stochastics %K at 74.74% indicates the stock is a holding.
The most recent change occurred on January 21, 2022 when Macquarie began covering the stock and recommended ‘”an Outperform”‘ rating along with a $64 price target.
